
Identifying The Three Leading Ways Your ISS and ISE Can Derail Your Study
10 March 2020

New Requirements for Drugs to Treat Cancer for Pediatrics: What The RACE for Children Act Means for Sponsors
08 January 2020

Common Operational Considerations in Immuno Oncology Drug Development
20 November 2019

Anticipating Next Steps and Resources You’ll Need In Clinical Trial Data Submission
22 October 2019

Are You Asking The Right Questions to Determine Early Phase Oncology Trial Design?
04 October 2019